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RESEARCH SUMMARY

A longitudinal study of
patients on antiretroviral
therapy (ART) found that
levels of internalized stigma
decreased after 12 months
on treatment. Participants
also disclosed to a greater
number of family members.
Despite these positive
changes, internalized stigma
remains a problem for many
respondents and warrants
increased stigma reduction
activities in the community.

PAUL MUNYAO

Changes in Stigma among a Cohort of
People on Antiretroviral Therapy:
Findings from Mombasa, Kenya

Bamburi Health Centre in Mombasa where study
respondents accessed ART.

S

toward PLHIV. However, little is known in developing countries about whether perceptions and
experiences of stigma among PLHIV have changed
following increased access to ART.

In the industrialized world, the availability of ART
and a subsequent change in perception of AIDS as
a chronic manageable disease has coincided with
a decrease in stigma and discrimination directed

In response to this gap, researchers from the Horizons Program and the International Centre for
Reproductive Health undertook an observational
study in Mombasa, Kenya, to document changes in
internalized and experienced stigma in a cohort of
HIV-infected persons over a 12-month period after
initiating ART. The study was conducted in collaboration with Coast Province General Hospital,
Mkomani Bomu Clinic, and Port Reitz District
Hospital.

tigma has been a reality in the lives of people
living with HIV (PLHIV) since the inception
of the AIDS epidemic. PLHIV have reported
experiencing stigma in a variety of ways including
isolation, rejection, withholding of emotional and
financial support, denial of health services, and loss
of employment. These manifestations of stigma can
have profound implications for the health, psychosocial well-being, and utilization of health services
by PLHIV (UNAIDS 2001; Alubo et al. 2002).

To read more about this study, go to

www.popcouncil.org/horizons/projects/Kenya_HAARTMombasa.htm

Methodology

Horizons conducts global operations
research to improve HIV/AIDS
prevention, care, and support
programs. Horizons is implemented by
the Population Council in partnership
with the International Center for
Research on Women (ICRW), PATH,
the International HIV/AIDS Alliance,
Tulane University, Family Health
International, and Johns Hopkins
University.

Key Findings

The researchers conducted semi-structured interviews at health facilities with
a cohort of HIV-infected persons prior
to starting ART and after 12 months on
treatment. The interviewers were trained
in building rapport, maintaining confidentiality, and using non-judgemental
data collection techniques. All patients
received standard adherence counseling
consisting of three preparatory sessions
before the initiation of ART and ongoing counseling
for the duration of the study.

Internalized stigma declined significantly after 12 months on treatment,
particularly among women. Nearly
three-quarters (73 percent) of respondents reported moderate to high internalized stigma at baseline. As shown
in Figure 1, the proportion reporting
moderate to high internalized stigma
declined significantly after 12 months
on treatment (p < .001); correspondingly, the proportion reporting minimal to low stigma
increased significantly at follow up.

Internalized stigma was measured using a 16-item scale
(Cronbach’s alpha 0.81; possible range of scores 16–64)
adapted from the HIV Stigma scale (Berger, Ferrans,
and Lashley 2001). The scale covered four domains:
personalized stigma, disclosure concerns, negative
self-image, and concern with public attitudes toward
PLHIV. Using a 4-point Likert scale, respondents indicated their level of agreement with each item (strongly
disagree, disagree, agree, and strongly agree). The scores
were categorized into minimal to low stigma (16–40)
and moderate to high stigma (41–64). Experienced
stigma within the family, community, and workplace
was assessed by asking respondents about people's reactions after they disclosed their HIV status in these
settings. Respondents were also asked whether they
received any form of support or encouragement from
these individuals.

At baseline more women than men reported moderate
to high internalized stigma (71 vs. 65 percent). After
12 months on treatment, there were significant declines
in the proportion of both women (71 vs. 60 percent; p
= 0.018) and men (65 vs. 51 percent; p = 0.007) who
reported moderate to high internalized stigma.

Sociodemographic Characteristics
A total of 181 participants were followed over 12
months and completed both baseline and endline
interviews. Most of the sample was female (63 percent). The mean age was 37 years (SD 7.93) and
84 percent had completed primary school. Almost
half (48 percent) were married or cohabitating, 15
percent were single, 14 percent were divorced or
separated, and 23 percent were widowed.
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There was no association between internalized stigma
and age or marital status.
Figure 1 Classification of participants by internalized
stigma scores at baseline and follow up
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The Ethical Review Board of Kenyatta National
Hospital, Kenya, and the Institutional Review
Board of the Population Council, USA, gave ethical approval for the study. All interviewees provided informed consent prior to the interviews.

When examining mean scores to measure internalized
stigma, women reported significantly higher mean
scores compared to men at baseline (45.7 vs. 43.3; p
= 0.035). The mean scores declined for both groups,
although the decline was greater among women. At
follow up, women and men had similar mean scores
(41.78 vs. 40.34; p = 0.215).
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Participants disclosed to a significantly greater number of family members after 12 months on treatment.
At baseline, the vast majority (85 percent) of respondents had disclosed their HIV status to someone in
the family. While this increased slightly to 90 percent,
the difference was not statistically significant. But the
number of family members to whom participants had
disclosed their HIV status increased significantly over
time from a median of two family members at baseline
to a median of three family members at follow up (p <
0.001).
Among married or cohabiting respondents disclosure
to spouses was high at baseline (80 percent; n = 101)
and at follow up (83 percent; n = 88). Figure 2 shows
changes in disclosure rates to other family members. At
both baseline and endline, disclosure was most often
to siblings and parents. Disclosure to all categories of
family members increased at endline, but the difference
was only statistically significantly to parents (p = 0.05)
and children (p = 0.004).
Positive support from family members was very high
at baseline and remained high at endline. Study participants who had disclosed their HIV status to family
members were asked about their relatives' reactions at
baseline and endline. During both interviews, nearly
all respondents reported that they had received positive
support from at least one family member. Emotional
support was the most frequently reported type of support the participants received followed by financial support and physical care. Siblings and spouses/partners
were the most frequently cited source of support in the
family. Less than 10 percent reported having experienced a negative reaction from a family member. These
included “don’t visit me,” “don’t touch me,” “don’t eat
or sit with me,” “deserted me,” “verbally abused me,”
“threw me out of the house,” and “hid me in a corner.”

There was no change in disclosure rates to community
members. At baseline, only about a fourth of respondents disclosed to a community member and there was
little change at endline. Study participants mainly disclosed to friends, neighbors, and religious leaders. The
proportion of respondents disclosing their HIV status
to a neighbor, health worker, and in a PLHIV support
group increased after 12 months on treatment, but the
differences were not statistically significant.

Figure 2 Disclosure to family members at baseline
and follow up
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Most respondents who had disclosed to someone in the
community reported that they had received some form
of support; less than 10 percent reported a negative
reaction. Very few respondents (less than 4 percent)
who disclosed their HIV status to someone in the community reported experiencing a stigmatizing event in
public, such as being called a derogatory name or being
refused service in a restaurant.
The most frequently mentioned reasons at baseline
for not disclosing their HIV status to someone in the
community were fear of verbal abuse, gossip, and being
isolated and these fears did not diminish at endline.
Although it not a principal reason for not disclosing,
the proportion of respondents who feared that they or
their family would be rejected decreased significantly at
endline (15 vs. 5 percent; p = 0.035).
Disclosure at the workplace was low, yet participants
received positive support from the individuals they
disclosed to. At baseline 30 percent (n = 54) of the
respondents were employed. This figure increased to 35
percent (n = 64) a year later. Disclosure to colleagues
at work by employed respondents increased from 15
percent at baseline to 22 percent at endline, but the
difference was not statistically significant. Overall, colleagues and employers were supportive of participants,
who had dsiclosed providing mostly psychological and
physical support. The most commonly mentioned
reasons for not disclosing at the workplace were fear
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of rumors/gossip, fear of isolation, and fear of losing
their job. Overall, there were no significant differences
between baseline and endline regarding the reasons for
not disclosing in the workplace, except for a significant
decrease in fear of verbal abuse (17 vs. 6 percent; p <
0.05).

Conclusions
The study found that levels of internalized stigma
decreased among participants. Before initiating ART,
many study participants reported a moderate to high
level of internalized stigma. However, after 12 months
on ART, the proportion of patients in this category declined significantly. In addition, the study revealed that
participants disclosed to a significantly greater number
of family members over time, especially to children.
But there was no change in disclosure rates in the community or at the workplace.
Only a small proportion of participants reported experiencing a negative or stigmatizing event in the family,
community, or at the workplace. Within the family
nearly all participants reported receiving psychological,
financial, and/or physical support. Fears of rejection by
the community and of verbal abuse at the workplace
declined significantly at follow up.
Due to a lack of a control group, it is not possible to
conclude that access to ART reduced internalized stigma and increased disclosure to more family members.
But the data do indicate a strong association between
initiation of ART and more favorable stigma and disclosure outcomes. A possible explanation for this association is that being on ART improved participants’
physical health, which contributed to improvements
in their self-image and self-worth, and reductions in
their fears of disclosure and negative public attitudes.
It is also likely that ongoing stigma-reduction efforts in
Mombasa, such as red-ribbon campaigns and information dissemination about transmission, have contributed to the study’s positive outcomes.
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In this particular setting where access to ART has increased greatly, family members appear to be the easiest
for participants to approach to disclose their serostatus,
whereas the community and workplace remain much
more formidable outlets. More research using qualitative methods is needed to better understand the reasons
for non-disclosure in the community with regard to
privacy and trust issues, and expectations of support
from workmates and the community.
Finally, although the researchers observed a reduction
in internalized stigma, a substantial proportion of both
women and men reported moderate to high levels at
follow up. Therefore, in addition to increased and sustained availability of ART, more stigma reduction interventions are warranted in this community.
December 2007
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